Merger activity increased last week with four new deals announced and four pending deals closing.
Deal Statistics:
New Deals:
- The acquisition of Immune Design (IMDZ) by Merck (MRK) for $300 million or $5.85 per share in cash.
- The acquisition of Citizens First Corporation (CZFC) by German American Bancorp (GABC) for $69.51 million in a cash plus stock deal. Under the terms of the definitive agreement, Citizens First common shareholders (excluding 401(k) shareholders) will receive a fixed exchange ratio of 0.6629 shares of German American common stock for each share of Citizens First in a tax-free